Rocket


Overview
Financials
News + Filings

 
 

Accelerated Pharma, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15
Revenues0.00.00.0
            Revenue growth-100.0%  
Cost of goods sold0.00.00.0
Gross profit0.00.00.0
            Gross margin 100.0% 
Research and development0.00.22.3
General and administrative0.73.01.5
EBIT-0.7-3.2-3.8
            EBIT margin -6404736.0% 
Pre-tax income-1.4-3.90.0
Income taxes0.00.00.0
            Tax rate0.0%0.0% 
Net income-1.4-3.90.0
            Net margin -7859720.0% 
 
Diluted EPS($0.24)($0.79)$0.00
Shares outstanding (diluted)5.85.04.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy